These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32780352)

  • 21. Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains.
    Helboe L; Rosenqvist N; Volbracht C; Pedersen LØ; Pedersen JT; Christensen S; Egebjerg J; Christoffersen CT; Bang-Andersen B; Beach TG; Serrano GE; Falsig J
    J Alzheimers Dis; 2022; 88(1):207-228. PubMed ID: 35570492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSK3 and tau: two convergence points in Alzheimer's disease.
    Hernandez F; Lucas JJ; Avila J
    J Alzheimers Dis; 2013; 33 Suppl 1():S141-4. PubMed ID: 22710914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological Changes of Tau Related to Alzheimer's Disease.
    Chu D; Liu F
    ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Copper in Tau-Related Pathology in Alzheimer's Disease.
    Zubčić K; Hof PR; Šimić G; Jazvinšćak Jembrek M
    Front Mol Neurosci; 2020; 13():572308. PubMed ID: 33071757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease.
    Liu X; Lai LY; Chen JX; Li X; Wang N; Zhou LJ; Jiang XW; Hu XL; Liu WW; Jiao XM; Qi ZT; Liu WJ; Wu LM; Huang YG; Xu ZH; Zhao QC
    Neuropharmacology; 2023 Jul; 232():109525. PubMed ID: 37004752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions.
    Zhu H; Zhang W; Zhao Y; Shu X; Wang W; Wang D; Yang Y; He Z; Wang X; Ying Y
    Mol Neurodegener; 2018 Nov; 13(1):62. PubMed ID: 30466464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau
    Miao J; Shi R; Li L; Chen F; Zhou Y; Tung YC; Hu W; Gong CX; Iqbal K; Liu F
    Front Aging Neurosci; 2019; 11():34. PubMed ID: 30890929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NAP Protects against Tau Hyperphosphorylation Through GSK3.
    Ivashko-Pachima Y; Gozes I
    Curr Pharm Des; 2018; 24(33):3868-3877. PubMed ID: 30417779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dimethyl Fumarate Mitigates Tauopathy in Aβ-Induced Neuroblastoma SH-SY5Y Cells.
    Rajput MS; Nirmal NP; Rathore D; Dahima R
    Neurochem Res; 2020 Nov; 45(11):2641-2652. PubMed ID: 32816241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A three-dimensional human neural cell culture model of Alzheimer's disease.
    Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
    Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo.
    Lu J; Miao J; Su T; Liu Y; He R
    Biochim Biophys Acta; 2013 Aug; 1830(8):4102-16. PubMed ID: 23628704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morin attenuates tau hyperphosphorylation by inhibiting GSK3β.
    Gong EJ; Park HR; Kim ME; Piao S; Lee E; Jo DG; Chung HY; Ha NC; Mattson MP; Lee J
    Neurobiol Dis; 2011 Nov; 44(2):223-30. PubMed ID: 21782947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses.
    Meng JX; Zhang Y; Saman D; Haider AM; De S; Sang JC; Brown K; Jiang K; Humphrey J; Julian L; Hidari E; Lee SF; Balmus G; Floto RA; Bryant CE; Benesch JLP; Ye Y; Klenerman D
    Nat Commun; 2022 May; 13(1):2692. PubMed ID: 35577786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontotemporal Dementia P301L Mutation Potentiates but Is Not Sufficient to Cause the Formation of Cytotoxic Fibrils of Tau.
    Wang KW; Zhang G; Kuo MH
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation.
    Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ
    CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Interplay between GSK3β and Tau Ser262 Phosphorylation during the Progression of Tau Pathology.
    Song L; Oseid DE; Wells EA; Robinson AS
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.